TAGRISSO 40MG TABLET

Form: Tablets

Pack Size: 10 TABLETS

Marketed by: ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV)

MRP: ₹137893.00

ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV): Tagrisso 40MG Tablet, 10 tablets, salt osimertinib 40mg. Its MRP stays at Rs 137,893 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 105,061.33. Group: third-generation EGFR inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: once daily; check the strength (40 or 80 mg) against the prescription. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.